Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1998
05/05/1998US5747654 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/05/1998US5747649 Acellular red blood cell substitute
05/05/1998US5747646 Polyethylene-protein conjugates
05/05/1998US5747645 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
05/05/1998US5747642 Monomeric insulin analog formulations
05/05/1998US5747641 Tat-derived transport polypeptide conjugates
05/05/1998US5747639 Use of hydrophobic interaction chromatography to purify polyethylene glycols
05/05/1998US5747545 Method of preventing NMDA receptor complex-mediated Neuronal damage
05/05/1998US5747532 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
05/05/1998US5747504 Administering n-alanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as hypotensive agents
05/05/1998US5747470 Anticarcinogenic agents, viricides
05/05/1998US5747469 Methods and compositions comprising DNA damaging agents and p53
05/05/1998US5747461 Synergistic administration of cyclosporine and fructose diphosphate
05/05/1998US5747460 Method of treatment and prophylaxis of venous thrombosis
05/05/1998US5747459 Method for insuring adequate intracellular glutathione in tissue
05/05/1998US5747458 Plasminogen activator of protease and tripeptides
05/05/1998US5747457 Linear adhesion inhibitors
05/05/1998US5747456 Continuous low-dose administration of parathyroid hormone or its agonist
05/05/1998US5747455 Biochemical immobilization for endotoxin based proteins
05/05/1998US5747454 Chromogranin peptides
05/05/1998US5747453 Destabilizing bioactive amino acid sequences with residue replacements; drug delivery
05/05/1998US5747452 Method of modulating tumor cell migration using fibronectin type III peptides
05/05/1998US5747451 Diagnosis and prevention of arteriosclerosis
05/05/1998US5747449 Bovine pancreatic trypsin inhibitor derived inhibitors of factor XA
05/05/1998US5747447 Stable polypeptide composition
05/05/1998US5747446 Modified polypeptides with increased biological activity
05/05/1998US5747445 Insulin with bile salts for enhancing absorption for breathing
05/05/1998US5747444 Anticarcinogenic agents and interleukin-1
05/05/1998US5747335 Ribozymes
05/05/1998US5747334 Random peptide library
05/05/1998US5747330 Cyclosporin-producing tolypocladium fungi
05/05/1998US5747329 Glutamylcysteine synthetase light subunit
05/05/1998US5747326 Isolated nucleic acid molecules which encode mammalian α2,8 polysialyl transferases
05/05/1998US5747324 Plasmid vectors for insertion in dna for pox virus vectors, prokarotic origin and dna sequences
05/05/1998US5747319 Human mRNA editing enzyme
05/05/1998US5747318 Mitogen activated c-Fos regulating kinase, FRK
05/05/1998US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747314 Nucleotides and genetic vectors
05/05/1998US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747312 Dna and rna codes for genetic engineering and treatment of mutations and diseases
05/05/1998US5747303 Intermediates of peptide antagonists of neurotensin
05/05/1998US5747296 Polypeptides for genetic engineering
05/05/1998US5747295 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T
05/05/1998US5747294 Antibody formed by hybridomas produced using cells from animal immunized with borrelia burgdorferi
05/05/1998US5747292 Chimeric cytokine receptors in lymphocytes
05/05/1998US5747291 Plasmids for production of enzyme urokinase for thrombolytic agents
05/05/1998US5747290 Process for the production of recombinant polypeptides
05/05/1998US5747288 Protein kinase required for Ras signal transduction
05/05/1998US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae
05/05/1998US5747283 Polynucleotides, dna codes and antibodies for medical diagnosis and treatment of antiinflammatory conditions and anthelmintics
05/05/1998US5747282 Dna and cloning vectors for production of cloning vectors and gene expression for screening potential cancer therapy
05/05/1998US5747280 Human vascular IBP-like growth factor
05/05/1998US5747279 Nucleic acid molecules encoding kappa3 opioid receptors, receptors encoded thereby, and uses thereof
05/05/1998US5747275 Protein kinase required for RAS signal transduction
05/05/1998US5747269 Determination of peptide motifs on MHC molecules
05/05/1998US5747267 Method for identifying a G protein coupled glutamate receptor agonist and antagonist
05/05/1998US5747262 Neurological drug screens
05/05/1998US5747261 Cancer treatment; genetic engineering
05/05/1998US5747250 Probe for tumour diagnostics or tumour therapy
05/05/1998US5747245 Nucleic acids encoding Fas associated proteins and screening assays using same
05/05/1998US5747072 Adenoviral-mediated gene transfer to synovial cells in vivo
05/05/1998US5747069 Monoglyceride and fatty acid promoters; tachykinin antagonists
05/05/1998US5747058 High viscosity liquid controlled delivery system
05/05/1998US5747048 Antigrowth agents agents for cancer cell
05/05/1998US5747047 Purified mite allergen
05/05/1998US5747045 Immunogenic amount of recombitant vp1 capsid protein of avian polyomavirus mixed with carrier
05/05/1998US5747043 Cucumis melo protein extract with antioxidant activity and process for preparing it, cosmetic composition or food composition containing such an extract
05/05/1998US5747040 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
05/05/1998US5747037 Monoclonal antibodies bound to epitopes secreted by hybridomas
05/05/1998US5747036 Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
05/05/1998US5747035 Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
05/05/1998US5747034 Methods and materials for the induction of T cell anergy
05/05/1998US5747032 Monoclonal antibody to human granulocyte macrophage colony stimulating factor
05/05/1998US5747031 Process for isolating immunoglobulins in whey
05/05/1998US5747030 Pharmaceutical preparation containing plasminogen activators
05/05/1998US5747027 Dna codes, vectors and polypeptides
05/05/1998US5747026 Antioxidants
05/05/1998US5747024 Vaccine adjuvant comprising interleukin-15
05/05/1998US5747023 Cancer therapy using lymphotoxin
05/05/1998US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
05/05/1998US5746223 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis
05/05/1998CA1339858C Human monoclonal antibodies specific for gp120 and gp41 and hybridomas for their production
05/05/1998CA1339857C Monoclonal antibodies to gp120 which neutraleze hiv-1
05/05/1998CA1339853C Sf-25 colon adenocarcinoma antigen, and antibodies which recognize thisantigen
04/1998
04/30/1998WO1998017826A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus
04/30/1998WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998WO1998017809A1 Methods of reducing the levels of protoporphyrin ix in recombinant hemoglobin preparations
04/30/1998WO1998017807A1 Pancreatic lipases and/or recombinant colipases and derived polypeptides produced by plants, methods for obtaining them and use thereof
04/30/1998WO1998017806A1 Mini-e1a genes and gene products
04/30/1998WO1998017805A2 Invasion associated genes from neisseria meningitidis serogroup b
04/30/1998WO1998017804A2 A HELICOBACTER ANTIGEN (η-GLUTAMYLTRANSFERASE) AND SEQUENCES ENCODING THE SAME
04/30/1998WO1998017801A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-α NUCLEIC ACIDS
04/30/1998WO1998017800A1 Novel human cc chemokine larc
04/30/1998WO1998017799A1 Immunotherapy and improved vaccines
04/30/1998WO1998017798A1 Placental-derived prostate growth factors
04/30/1998WO1998017797A1 ANTI-ErbB2 ANTIBODIES
04/30/1998WO1998017796A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998WO1998017795A1 Nucleic acid encoding ds-cam proteins and products related thereto
04/30/1998WO1998017794A1 Human eosinophil-derived basic protein
04/30/1998WO1998017793A1 Fringe proteins and notch signalling
1 ... 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 ... 3163